Trinity Biotech has a one year ... the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products ...
Trinity Biotech has a 12-month ... the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products ...
The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...
TipRanks on MSN8d
Trinity Biotech’s CGM System Shows Breakthrough ImprovementsTrinity Biotech ( ($TRIB) ) has shared an update. On February 6, 2025, Trinity Biotech announced significant improvements in its continuous ...
DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
The company is gearing up for regulatory submissions in Europe in 2025 and plans to file with the U.S. FDA in 2026. Trinity Biotech is also preparing for additional pre-pivotal clinical trials in ...
DUBLIN, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
DUBLIN, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including ...
The company is gearing up for regulatory submissions in Europe in 2025 and plans to file with the U.S. FDA in 2026. Trinity Biotech is also preparing for additional pre-pivotal clinical trials in Q1 ...
Trinity Biotech's two rapid HIV tests will continue to be funded under PEPFAR, a significant global initiative to combat HIV/AIDS. The company confirmed that other testing programs using their ...
Trinity Biotech's two rapid HIV tests will continue to be funded under PEPFAR, a significant global initiative to combat HIV/AIDS. The company confirmed that other testing programs using their rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback